Proteasome inhibition reduces coxsackievirus B3 replication in murine cardiomyocytes

scientific article published on August 2003

Proteasome inhibition reduces coxsackievirus B3 replication in murine cardiomyocytes is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0002-9440(10)63667-X
P932PMC publication ID1868224
P698PubMed publication ID12875959

P2093author name stringBruce M McManus
Decheng Yang
Honglin Luo
Agripina Suarez
Caroline Cheung
Jingchun Zhang
P2860cites workA role for ubiquitin ligase recruitment in retrovirus releaseQ24642874
Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2Q24643016
In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C proteaseQ28343611
The ubiquitin-proteasome pathway and proteasome inhibitorsQ28367002
The ubiquitin-proteasome pathway: on protein death and cell lifeQ29619270
Protein regulation by monoubiquitinQ29620221
HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyteQ29620367
Proteasome inhibitors: valuable new tools for cell biologistsQ29620573
Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathwayQ34333784
Viral infection and the pathogenesis of dilated cardiomyopathyQ34348615
Development of the proteasome inhibitor PS-341.Q34537877
A beta-lactone related to lactacystin induces neurite outgrowth in a neuroblastoma cell line and inhibits cell cycle progression in an osteosarcoma cell lineQ35171318
Progress and challenges in the pathological diagnosis of myocarditisQ36428835
Ubiquitin is part of the retrovirus budding machineryQ37281238
The tumor suppressor protein p53 strongly alters human immunodeficiency virus type 1 replicationQ38306433
X-gene product antagonizes the p53-mediated inhibition of hepatitis B virus replication through regulation of the pregenomic/core promoterQ38531299
Ubiquitin-dependent proteolysis of cyclin D1 is associated with coxsackievirus-induced cell growth arrestQ39698538
Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitroQ39752763
Direct interactions of coxsackievirus B3 with immune cells in the splenic compartment of mice susceptible or resistant to myocarditisQ39875225
Ubiquitin, proteasomes, and the regulation of intracellular protein degradationQ40445002
Ubiquitin/proteasome-dependent degradation of D-type cyclins is linked to tumor necrosis factor-induced cell cycle arrestQ40748304
Intermolecular phosphorylation between insulin holoreceptors does not stimulate substrate kinase activityQ42818894
Evidence that inhibition of p44/42 mitogen-activated protein kinase signaling is a factor in proteasome inhibitor-mediated apoptosisQ44002712
Induction of G1 arrest and selective growth inhibition by lactacystin in human umbilical vein endothelial cells.Q54571909
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectCoxsackievirusQ1138287
P304page(s)381-385
P577publication date2003-08-01
P1433published inThe American Journal of PathologyQ4744259
P1476titleProteasome inhibition reduces coxsackievirus B3 replication in murine cardiomyocytes
P478volume163

Reverse relations

cites work (P2860)
Q47547539A novel role of ER stress signal transducer ATF6 in regulating enterovirus A71 viral protein stability.
Q34150998A small-molecule inhibitor of deubiquitinating enzyme USP14 inhibits Dengue virus replication
Q36385481Autoimmunity in coxsackievirus B3 induced myocarditis
Q36524801Broad and potent antiviral activity of the NAE inhibitor MLN4924.
Q47315412Cleavage of osmosensitive transcriptional factor NFAT5 by Coxsackieviral protease 2A promotes viral replication
Q35732935Cleavage of serum response factor mediated by enteroviral protease 2A contributes to impaired cardiac function
Q24630927Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century
Q33326624Different effect of proteasome inhibition on vesicular stomatitis virus and poliovirus replication
Q41161957Dysferlin deficiency confers increased susceptibility to coxsackievirus-induced cardiomyopathy
Q42797471Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication
Q34356945ER stress-mediated apoptosis induced by celastrol in cancer cells and important role of glycogen synthase kinase-3β in the signal network
Q36705558Efficacy and Safety of Bortezomib in Multiple Myeloma Patients with Hepatitis B: A Multicenter Retrospective Study.
Q35544380Human Pirh2 is a novel inhibitor of prototype foamy virus replication
Q33781261Inhibition of coxsackievirus B3 replication by small interfering RNAs requires perfect sequence match in the central region of the viral positive strand
Q37110640Inhibition of the ubiquitin-proteasome system prevents vaccinia virus DNA replication and expression of intermediate and late genes
Q51130109Modification of SARS-CoV S1 gene render expression in Pichia pastoris.
Q37937617Multifaceted roles of curcumin: two sides of a coin!
Q38728290Newcastle disease virus degrades HIF-1α through proteasomal pathways independent of VHL and p53.
Q35088241Ongoing coxsackievirus myocarditis is associated with increased formation and activity of myocardial immunoproteasomes
Q36302442PA28 modulates antigen processing and viral replication during coxsackievirus B3 infection
Q34223177Pharmacological and biological antiviral therapeutics for cardiac coxsackievirus infections.
Q59804795Proteasomal Protein Degradation: Adaptation of Cellular Proteolysis With Impact on Virus-and Cytokine-Mediated Damage of Heart Tissue During Myocarditis
Q36080090Proteasome Inhibition Contributed to the Cytotoxicity of Arenobufagin after Its Binding with Na, K-ATPase in Human Cervical Carcinoma HeLa Cells.
Q34190751Proteasome activator REGgamma enhances coxsackieviral infection by facilitating p53 degradation
Q39976598Proteasome inhibition attenuates coxsackievirus-induced myocardial damage in mice
Q39985514Proteasome inhibition reduces avian reovirus replication and apoptosis induction in cultured cells
Q37541537Protein degradation systems in viral myocarditis leading to dilated cardiomyopathy
Q50025561Pyroptosis induced by enterovirus 71 and coxsackievirus B3 infection affects viral replication and host response
Q37036711Pyrrolidine dithiocarbamate inhibits herpes simplex virus 1 and 2 replication, and its activity may be mediated through dysregulation of the ubiquitin-proteasome system
Q42847096Pyrrolidine dithiocarbamate reduces coxsackievirus B3 replication through inhibition of the ubiquitin-proteasome pathway
Q40097756Reduction of infectious bursal disease virus replication in cultured cells by proteasome inhibitors
Q35531278Replication of the rotavirus genome requires an active ubiquitin-proteasome system
Q43207997Synthesis, antibacterial and antiviral properties of curcumin bioconjugates bearing dipeptide, fatty acids and folic acid
Q92404517The Capsid Protein VP1 of Coxsackievirus B Induces Cell Cycle Arrest by Up-Regulating Heat Shock Protein 70
Q45373236The Ubiquitin-Proteasome System Regulates the Accumulation ofTurnip yellow mosaic virusRNA-Dependent RNA Polymerase during Viral Infection
Q33855429The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling
Q42738022The proteasome inhibitor Velcade enhances rather than reduces disease in mouse hepatitis coronavirus-infected mice.
Q22242631The role of infections in autoimmune disease
Q40543452The ubiquitin-proteasome machinery is essential for nuclear translocation of incoming minute virus of mice
Q36538328The ubiquitin-proteasome pathway in viral infections
Q38989110The ubiquitin-proteasome system is required for the early stages of porcine circovirus type 2 replication
Q34190714Toll-like receptor 4-mediated activation of p38 mitogen-activated protein kinase is a determinant of respiratory virus entry and tropism
Q82753223Tripeptidyl peptidase II serves as an alternative to impaired proteasome to maintain viral growth in the host cells
Q112033680Ubiquitin-Modified Proteome of SARS-CoV-2-Infected Host Cells Reveals Insights into Virus-Host Interaction and Pathogenesis
Q38115330Ubiquitin-like protein modifiers and their potential for antiviral and anti-HCV therapy.
Q33350188Ubiquitination is required for effective replication of coxsackievirus B3.
Q38052447Viral myocarditis: from experimental models to molecular diagnosis in patients
Q37333951Viral persistence and chronic immunopathology in the adult central nervous system following Coxsackievirus infection during the neonatal period
Q39902786West Nile virus genome amplification requires the functional activities of the proteasome

Search more.